Table 2 Percentage of patients on monotherapy according to treatment course and drug

Number of patients

79

25

9

2

115

% Patients on biologic monotherapy at initiation of biologics (95 % CI)

24 (15–35)

60 (39–79)

44 (14–79)

100

35 (26–44)

% Patients on biologic monotherapy at initiation of biologics due to Medical prescription (95 % CI)

15 (8–25)

48 (28–69)

33 (7–70)

0 (0)

23 (16–32)

% Patients biologic monotherapy at initiation of biologics, due to patient’s decision (95 % CI)

9 (3.6–17)

12 (2.5–31)

11 (0.2–48)

100

11 (6–18)